176 related articles for article (PubMed ID: 38124732)
41. Interferon Inhibition for Lupus with Anifrolumab: Critical Appraisal of the Evidence Leading to FDA Approval.
Loncharich MF; Anderson CW
ACR Open Rheumatol; 2022 Jun; 4(6):486-491. PubMed ID: 35157371
[TBL] [Abstract][Full Text] [Related]
42. Association of STAT4 gene single nucleotide polymorphisms with Iranian juvenile-onset systemic lupus erythematosus patients.
Salmaninejad A; Mahmoudi M; Aslani S; Poursani S; Ziaee V; Rezaei N
Turk J Pediatr; 2017; 59(2):144-149. PubMed ID: 29276866
[TBL] [Abstract][Full Text] [Related]
43. A Bayesian gene network reveals insight into the JAK-STAT pathway in systemic lupus erythematosus.
Li Y; Higgs RE; Hoffman RW; Dow ER; Liu X; Petri M; Wallace DJ; Dörner T; Eastwood BJ; Miller BB; Liu Y
PLoS One; 2019; 14(12):e0225651. PubMed ID: 31790472
[TBL] [Abstract][Full Text] [Related]
44. Type I IFN signature in childhood-onset systemic lupus erythematosus: a conspiracy of DNA- and RNA-sensing receptors?
Wahadat MJ; Bodewes ILA; Maria NI; van Helden-Meeuwsen CG; van Dijk-Hummelman A; Steenwijk EC; Kamphuis S; Versnel MA
Arthritis Res Ther; 2018 Jan; 20(1):4. PubMed ID: 29321042
[TBL] [Abstract][Full Text] [Related]
45. EZH2 Inhibition Interferes With the Activation of Type I Interferon Signaling Pathway and Ameliorates Lupus Nephritis in NZB/NZW F1 Mice.
Wu L; Jiang X; Qi C; Zhang C; Qu B; Shen N
Front Immunol; 2021; 12():653989. PubMed ID: 33868295
[TBL] [Abstract][Full Text] [Related]
46. Genome-wide DNA methylation analysis implicates enrichment of interferon pathway in African American patients with Systemic Lupus Erythematosus and European Americans with lupus nephritis.
Allen PC; Roberts K; Rubio JE; Tiwari HK; Absher DM; Cooper SJ; Myers RM; Brown EE
J Autoimmun; 2023 Sep; 139():103089. PubMed ID: 37506491
[TBL] [Abstract][Full Text] [Related]
47. Does baricitinib reduce disease activity in patients with systemic lupus erythematosus? A systematic review and meta-analysis of randomized controlled trials.
Amer BE; Afifi E; Mouffokes A; Hamad AA; Amin AM; Abdelwahab OA
Clin Rheumatol; 2024 Feb; 43(2):579-589. PubMed ID: 37581759
[TBL] [Abstract][Full Text] [Related]
48. Molecular pathways in patients with systemic lupus erythematosus revealed by gene-centred DNA sequencing.
Sandling JK; Pucholt P; Hultin Rosenberg L; Farias FHG; Kozyrev SV; Eloranta ML; Alexsson A; Bianchi M; Padyukov L; Bengtsson C; Jonsson R; Omdal R; Lie BA; Massarenti L; Steffensen R; Jakobsen MA; Lillevang ST; ; Lerang K; Molberg Ø; Voss A; Troldborg A; Jacobsen S; Syvänen AC; Jönsen A; Gunnarsson I; Svenungsson E; Rantapää-Dahlqvist S; Bengtsson AA; Sjöwall C; Leonard D; Lindblad-Toh K; Rönnblom L
Ann Rheum Dis; 2021 Jan; 80(1):109-117. PubMed ID: 33037003
[TBL] [Abstract][Full Text] [Related]
49. State-of-the-art treatment of systemic lupus erythematosus.
Tanaka Y
Int J Rheum Dis; 2020 Apr; 23(4):465-471. PubMed ID: 32134201
[TBL] [Abstract][Full Text] [Related]
50. Baricitinib for the treatment of rheumatoid arthritis and systemic lupus erythematosus: a 2019 update.
Kubo S; Nakayamada S; Tanaka Y
Expert Rev Clin Immunol; 2019 Jul; 15(7):693-700. PubMed ID: 30987474
[No Abstract] [Full Text] [Related]
51. Identification of Cyclin-Dependent Kinase 1 as a Novel Regulator of Type I Interferon Signaling in Systemic Lupus Erythematosus.
Wu L; Qin Y; Xia S; Dai M; Han X; Wu Y; Zhang X; Ma J; Wang Y; Tang Y; Liu Z; Zhu W; Jallal B; Yao Y; Qu B; Shen N
Arthritis Rheumatol; 2016 May; 68(5):1222-32. PubMed ID: 26663909
[TBL] [Abstract][Full Text] [Related]
52. Relationship of systemic type I interferon activity with clinical phenotypes, disease activity, and damage accrual in systemic lupus erythematosus in treatment-naive patients: a retrospective longitudinal analysis.
Miyachi K; Iwamoto T; Kojima S; Ida T; Suzuki J; Yamamoto T; Mimura N; Sugiyama T; Tanaka S; Furuta S; Ikeda K; Suzuki K; Niewold TB; Nakajima H
Arthritis Res Ther; 2023 Feb; 25(1):26. PubMed ID: 36803843
[TBL] [Abstract][Full Text] [Related]
53. Juvenile systemic lupus erythematosus presenting as pancarditis.
O'Leary D; O'Connor C; Nertney L; MacDermott EJ; Mullane D; Franklin O; Killeen OG
Pediatr Rheumatol Online J; 2019 Nov; 17(1):71. PubMed ID: 31684978
[TBL] [Abstract][Full Text] [Related]
54. Higher activation of the interferon-gamma signaling pathway in systemic lupus erythematosus patients with a high type I IFN score: relation to disease activity.
Liu M; Liu J; Hao S; Wu P; Zhang X; Xiao Y; Jiang G; Huang X
Clin Rheumatol; 2018 Oct; 37(10):2675-2684. PubMed ID: 29774490
[TBL] [Abstract][Full Text] [Related]
55. Monogenic Lupus.
Lo MS
Curr Rheumatol Rep; 2016 Dec; 18(12):71. PubMed ID: 27812953
[TBL] [Abstract][Full Text] [Related]
56. A Novel Type I Interferon Primed Dendritic Cell Subpopulation in TREX1 Mutant Chilblain Lupus Patients.
Eugster A; Müller D; Gompf A; Reinhardt S; Lindner A; Ashton M; Zimmermann N; Beissert S; Bonifacio E; Günther C
Front Immunol; 2022; 13():897500. PubMed ID: 35911727
[TBL] [Abstract][Full Text] [Related]
57. Type 1 interferon suppresses expression and glucocorticoid induction of glucocorticoid-induced leucine zipper (GILZ).
Dankers W; Northcott M; Bennett T; D'Cruz A; Sherlock R; Gearing LJ; Hertzog P; Russ B; Miceli I; Scheer S; Fujishiro M; Hayakawa K; Ikeda K; Morand EF; Jones SA
Front Immunol; 2022; 13():1034880. PubMed ID: 36505447
[TBL] [Abstract][Full Text] [Related]
58. The
Hagberg N; Joelsson M; Leonard D; Reid S; Eloranta ML; Mo J; Nilsson MK; Syvänen AC; Bryceson YT; Rönnblom L
Ann Rheum Dis; 2018 Jul; 77(7):1070-1077. PubMed ID: 29475858
[TBL] [Abstract][Full Text] [Related]
59. The interferon-regulated gene signature is elevated in subacute cutaneous lupus erythematosus and discoid lupus erythematosus and correlates with the cutaneous lupus area and severity index score.
Braunstein I; Klein R; Okawa J; Werth VP
Br J Dermatol; 2012 May; 166(5):971-5. PubMed ID: 22242767
[TBL] [Abstract][Full Text] [Related]
60. JAK: Not Just Another Kinase.
Agashe RP; Lippman SM; Kurzrock R
Mol Cancer Ther; 2022 Dec; 21(12):1757-1764. PubMed ID: 36252553
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
